The involvement of many of the PAK1-regulated factors in such phenomena as cell motility, cell proliferation, and survival support the continuous interest in PAK1 among cancer researchers and has led to the recognition of this enzyme as a bona fide target for anti-cancer therapy [28]. The gene discussed is PAK1; the disease is cancer.